These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience. Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526 [TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of patients with Barrett's esophagus and high-grade dysplasia or early cancer treated with endoluminal therapies with intention to complete eradication. Guarner-Argente C; Buoncristiano T; Furth EE; Falk GW; Ginsberg GG Gastrointest Endosc; 2013 Feb; 77(2):190-9. PubMed ID: 23317687 [TBL] [Abstract][Full Text] [Related]
7. Endoscopic ablation of Barrett's neoplasia with a new focal radiofrequency device: initial experience with the Halo60. Allen B; Kapoor N; Willert R; McEwan H; Fullarton G; Penman I Endoscopy; 2012 Jul; 44(7):707-10. PubMed ID: 22723187 [TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes of a primary complete endoscopic resection strategy for short-segment Barrett's esophagus with high-grade dysplasia and/or early esophageal adenocarcinoma. Bahin FF; Jayanna M; Hourigan LF; Lord RV; Whiteman D; Williams SJ; Lee EY; Bourke MJ Gastrointest Endosc; 2016 Jan; 83(1):68-77. PubMed ID: 26096759 [TBL] [Abstract][Full Text] [Related]
14. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management. Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948 [TBL] [Abstract][Full Text] [Related]
15. An open-label, prospective trial of cryospray ablation for Barrett's esophagus high-grade dysplasia and early esophageal cancer in high-risk patients. Dumot JA; Vargo JJ; Falk GW; Frey L; Lopez R; Rice TW Gastrointest Endosc; 2009 Oct; 70(4):635-44. PubMed ID: 19559428 [TBL] [Abstract][Full Text] [Related]
16. Nitrous oxide cryotherapy for treatment of esophageal squamous cell neoplasia: initial multicenter international experience with a novel portable cryoballoon ablation system (with video). Canto MI; Abrams JA; Künzli HT; Weusten B; Komatsu Y; Jobe BA; Lightdale CJ Gastrointest Endosc; 2018 Feb; 87(2):574-581. PubMed ID: 28720474 [TBL] [Abstract][Full Text] [Related]
17. Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett's esophagus with early neoplasia: a prospective multicenter study. van Vilsteren FG; Alvarez Herrero L; Pouw RE; Schrijnders D; Sondermeijer CM; Bisschops R; Esteban JM; Meining A; Neuhaus H; Parra-Blanco A; Pech O; Ragunath K; Rembacken B; Schenk BE; Visser M; ten Kate FJ; Meijer SL; Reitsma JB; Weusten BL; Schoon EJ; Bergman JJ Endoscopy; 2013 Jul; 45(7):516-25. PubMed ID: 23580412 [TBL] [Abstract][Full Text] [Related]
18. Simplified protocol for focal radiofrequency ablation using the HALO90 device: short-term efficacy and safety in patients with dysplastic Barrett's esophagus. Künzli HT; Schölvinck DW; Phoa KN; Schoon EJ; Houben MH; Bergman JJ; Weusten BL Endoscopy; 2015 Jul; 47(7):592-7. PubMed ID: 25675174 [TBL] [Abstract][Full Text] [Related]
19. The diagnosis and management of Barrett's esophagus. DeMeester SR; DeMeester TR Adv Surg; 1999; 33():29-68. PubMed ID: 10572561 [TBL] [Abstract][Full Text] [Related]